IRMD.NASDAQIradimed CORP

Form 4: Iradimed Director Sells Shares

Sentiment:

Insider Transaction (Form 4)


Monty K Allen, a Director of Iradimed Corp, sold 1,419 shares of common stock on September 3, 2026.

Summary

  • Open-market sale: disposed of 1,014 Common Stock at $86.44 ($87,650) on September 3, 2026; holds 19,986 after (Direct).
  • Open-market sale: disposed of 405 Common Stock at $86.35 ($34,972) on September 3, 2026; holds 19,581 after (Direct).

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $122,622 of stock on the open market.

Insider Transactions

Monty K Allen — Director

DateTransactionSecuritySharesPriceValueHeld After
2026-09-03Open-market saleCommon Stock1,014$86$87.7K19,986
2026-09-03Open-market saleCommon Stock405$86$35.0K19,581

Key Dates

DateDescription
2026-09-03Open-market sale (1,014 shares)
2026-09-03Open-market sale (405 shares)

Keywords

insider transaction, Form 4, IRMD, IRADIMED CORP, bearish, Monty K Allen

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.